53 Active Substance Categories Subject to On-Site Inspections Prior to DMF Approval

Published: 2005-04-14 07:00:00

Updated: 2005-04-14 07:00:00

Reflective of the government's effort to officially implement the Pharmaceutical Bulk Report System scheduled by September of this year, the Korea Food and Drug Administration (KFDA) said it has selected 107 manufacturers with DMF (Drug Master File) submissions that are subject to the pre-approva...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK